written informed consent
Item
have signed a written informed consent
boolean
C0021430 (UMLS CUI [1])
b-cell chronic lymphocytic leukemia
Item
b-cll diagnosis
boolean
C0475774 (UMLS CUI [1])
rai stage
Item
rai stage 0, i, or ii
boolean
C1514715 (UMLS CUI [1])
previously untreated
Item
previously untreated
boolean
C0332155 (UMLS CUI [1])
waiting ability
Item
be able to watch and wait for approximately 8 months following submission of blood (or tissue) while id-klh is being manufactured
boolean
C0849176 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
leukemia treatment
Item
anti-leukemia treatment prior to beginning immunization
boolean
C0023418 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
other leukemia treatment
Item
anti-leukemia treatment other than id-klh during immunizations
boolean
C0023418 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
prior malignancy
Item
prior malignancy (excluding basal cell carcinoma and cervical carcinoma in situ)
boolean
C0006826 (UMLS CUI [1])
pregnancy, lactation
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
autoimmune diseases
Item
patients with known autoimmune disease (including previously treated autoimmune hemolytic anemia or immune thrombocytopenia)
boolean
C0004364 (UMLS CUI [1])
other clinical trial
Item
participation in any other clinical trial in which an investigational agent is administered
boolean
C2348568 (UMLS CUI [1])